Mathai Mammen, former J&J executive, to become FogPharma CEO

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 30, 2023 at 10:32: AM
via The veteran pharmaceutical executive was J&J’s head of R&D until his departure last August. He’s agreed to run FogPharma, a richly funded cancer drug startup.

article source
 

<



Similar threads

cafead
J&amp;J vet Mammen wanted board influence to be Biogen&#039;s next CEO, but chairman said no
Replies
0
Views
321
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Amy Abernethy teams with former Verily exec to improve data-driven clinical research
Replies
0
Views
14
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Two Senior Cassava Employees Subjects in Federal Probes After Former Advisor Indicted for Fraud
Replies
0
Views
13
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Former Stimwave CEO gets 6 years in prison for fake device scheme
Replies
0
Views
35
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Amarin&#039;s CEO resigns, leaving former interim chief to take over struggling drugmaker
Replies
0
Views
41
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote